For years, psychedelic research has focused on what happens during the trip: ego dissolution, emotional breakthroughs, increased neural connectivity, and shifts in perception.
Now researchers are starting to ask a deeper question: can psilocybin physically change the structure of the human brain itself?
According to a new study published in Nature Communications, the answer may be oui.
Scientists found that a single 25mg dose of psilocybin appeared to produce measurable anatomical changes in the brains of healthy volunteers, with effects still detectable one month later.
The findings are early, and researchers are being careful not to overstate them. But if confirmed, they could help explain why psychedelics continue showing promise for conditions like dépression, l'anxiété, dépendance, and rigid patterns of thinking.
What the Study Found
The research was led by Professor Robin Carhart-Harris, a neurologist at the University of California, San Francisco, alongside researchers at Imperial College London.
The study followed 28 healthy participants who had never taken psychedelics before.
To establish a baseline, researchers first gave volunteers a 1mg dose of psilocybin — small enough to function essentially as a placebo. During this phase, they monitored brain activity using electroencephalography (EEG), while participants also completed psychological tests measuring wellbeing, cognitive flexibility, and psychological insight.
Researchers additionally used functional MRI scans and diffusion tensor imaging (DTI), a specialised imaging technique that tracks the movement of water along nerve pathways in the brain.
A month later, participants returned and took a full 25mg dose of psilocybin.
That’s considered a high enough dose to produce a strong psychedelic experience.
The team then repeated the same brain scans and psychological assessments during the experience and over the following weeks.
Increased Brain “Entropy”
One of the key findings appeared almost immediately.
Within an hour of taking psilocybin, EEG scans showed a significant increase in what researchers call brain entropy.
In simple terms, entropy refers to variability and flexibility in brain activity. Under psilocybin, the brain appeared to process information in a less rigid and more dynamic way.
This lines up with what researchers call the “entropic brain hypothesis,” a theory suggesting psychedelics temporarily loosen fixed patterns of thought and perception.
That may help explain why people often describe psychedelic experiences as mentally expansive, emotionally fluid, or perspective-shifting.
It also fits with current theories around depression and addiction, where people can become trapped in repetitive cognitive loops.
Lasting Anatomical Changes
The more surprising findings came later.
One month after the psychedelic session, DTI scans revealed changes along nerve tracts connecting the front and middle regions of the brain.
Specifically, researchers observed reduced diffusion of water along these pathways.
That might sound technical, but it potentially points toward physical changes in neural structure.
Researchers suggested a few possible explanations.
One is pruning — the removal or refinement of certain neural connections. Another is the growth of new nerve fibres that have not yet fully developed their insulating sheaths.
At this stage, nobody knows for certain what the scans represent biologically. DTI offers an indirect view of brain structure rather than a direct visualisation.
Still, the fact that measurable changes persisted a month later caught researchers’ attention.
“It’s remarkable to see potential anatomical brain changes one month after a single dose of any drug,” Carhart-Harris said.
“We don’t yet know what these changes mean, but we do note that overall, people showed positive psychological changes in this study, including improved wellbeing and mental flexibility.”
The Link Between Flexibility and Mental Health
Another major finding involved the relationship between brain entropy and psychological outcomes.
Participants who showed the largest spike in entropy during the psychedelic experience were also the most likely to report deeper psychological insight and improved wellbeing a month later.
In other words, the more flexible and dynamic the brain became during the experience, the more meaningful the long-term psychological effects appeared to be.
Carhart-Harris said the findings point toward “a psychobiological therapeutic action for psilocybin.”
That idea has become increasingly central to psychedelic research over the last decade.
Rather than simply suppressing symptoms, psychedelics may temporarily disrupt rigid mental patterns, allowing the brain to reorganise itself in healthier ways.
What Neuroplasticity Has to Do With It
The concept underlying much of this research is neuroplasticity, AKA, the brain’s ability to reorganise and form new connections.
Animal studies have already shown that psychedelics can increase synaptic growth and rewiring in mice.
The big question has always been whether similar processes happen in humans.
Professor Alex Kwan, a neuroscientist at Cornell University, says this study gets closer than most to answering that question.
“Studies in mice have shown that psychedelics can rewire connections between nerves,” he said, describing it as a form of plasticity that could underlie the therapeutic effects of psychedelics.
“This study comes closer than most to addressing that question, by giving evidence of lasting changes in brain structure after psychedelic use.”
Still, Kwan stressed caution. The study involved a relatively small number of participants, and DTI scans provide only a limited and indirect picture of brain connectivity.
The findings are intriguing, but not yet definitive.
Why This Matters Beyond Psychedelics
The implications go beyond psychedelic science alone. Researchers noted that some of the apparent structural changes observed in the study resemble the opposite of what’s often seen in ageing and dementia, where neural pathways tend to weaken or degrade over time.
That doesn’t mean psilocybin reverses ageing or cures neurodegenerative disease. There’s not yet enough evidence to make claims like that. However, it does raise new questions about how psychedelics interact with long-term brain health.
Could temporary disruption create conditions for healthier neural organisation afterward?
Could increased flexibility help people break out of entrenched depressive or addictive patterns not just psychologically, but neurologically?
Those ideas are now being explored seriously inside neuroscience labs rather than fringe circles.
A Shift in How Psychedelics Are Understood
For decades, psychedelics were largely discussed in terms of hallucinations and altered consciousness.
That conversation is evolving.
Modern research increasingly frames compounds like psilocybin as tools capable of influencing emotion, cognition, inflammation, behaviour, and potentially even brain structure itself.
The newer studies are less focused on the visuals and more focused on plasticity — the brain’s capacity to adapt.
That shift matters because many mental health conditions involve rigidity. Depressive thought loops. Addictive behaviours. Fixed trauma responses. Anxiety spirals.
If psychedelics temporarily loosen those systems at both a psychological and neurological level, it may explain why even a single experience can sometimes produce lasting effects.
